Pagan Douglas W. 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Pagan Douglas W.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2021-12-15+2,050→ 8,377 total - Tax Payment
Common Stock
[F3]2021-12-15$38.05/sh−602$22,906→ 7,775 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2021-12-15−2,050→ 6,150 total→ Common Stock (2,050 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- [F3]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F4]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
Signature
/s/ Douglas Fambrough, attorney-in-fact|2021-12-17